table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer Targeted Small Molecule Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Targeted Small Molecule Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Targeted Small Molecule Therapy Overall Market Size
2.1 Global Cancer Targeted Small Molecule Therapy Market Size: 2022 VS 2029
2.2 Global Cancer Targeted Small Molecule Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Targeted Small Molecule Therapy Players in Global Market
3.2 Top Global Cancer Targeted Small Molecule Therapy Companies Ranked by Revenue
3.3 Global Cancer Targeted Small Molecule Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Targeted Small Molecule Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Targeted Small Molecule Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Players in Global Market
3.6.1 List of Global Tier 1 Cancer Targeted Small Molecule Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Targeted Small Molecule Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Targeted Small Molecule Therapy Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
4.2.1 By Type - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
4.2.2 By Type - Global Cancer Targeted Small Molecule Therapy Revenue, 2024-2029
4.2.3 By Type - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Targeted Small Molecule Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
5.2.1 By Application - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
5.2.2 By Application - Global Cancer Targeted Small Molecule Therapy Revenue, 2024-2029
5.2.3 By Application - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Targeted Small Molecule Therapy Market Size, 2022 & 2029
6.2 By Region - Global Cancer Targeted Small Molecule Therapy Revenue & Forecasts
6.2.1 By Region - Global Cancer Targeted Small Molecule Therapy Revenue, 2018-2023
6.2.2 By Region - Global Cancer Targeted Small Molecule Therapy Revenue, 2024-2029
6.2.3 By Region - Global Cancer Targeted Small Molecule Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.3.2 US Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.3 Canada Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.3.4 Mexico Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.4.2 Germany Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.3 France Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.4 U.K. Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.5 Italy Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.6 Russia Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.4.8 Benelux Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.5.2 China Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.3 Japan Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.4 South Korea Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.5.6 India Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.6.2 Brazil Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.6.3 Argentina Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Targeted Small Molecule Therapy Revenue, 2018-2029
6.7.2 Turkey Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.3 Israel Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
6.7.5 UAE Cancer Targeted Small Molecule Therapy Market Size, 2018-2029
7 Cancer Targeted Small Molecule Therapy Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Cancer Targeted Small Molecule Therapy Major Product Offerings
7.1.4 Bayer Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Cancer Targeted Small Molecule Therapy Major Product Offerings
7.2.4 Eisai Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Cancer Targeted Small Molecule Therapy Major Product Offerings
7.3.4 Zelgen Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Cancer Targeted Small Molecule Therapy Major Product Offerings
7.4.4 Cipla Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.5.4 Natco Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cancer Targeted Small Molecule Therapy Major Product Offerings
7.6.4 AstraZeneca Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Cancer Targeted Small Molecule Therapy Major Product Offerings
7.7.4 Novartis Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Cancer Targeted Small Molecule Therapy Major Product Offerings
7.8.4 Roche Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Cancer Targeted Small Molecule Therapy Major Product Offerings
7.10.4 Pfizer Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.11.4 BEACON Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Cancer Targeted Small Molecule Therapy Major Product Offerings
7.13.4 Yao Pharma Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Cancer Targeted Small Molecule Therapy Major Product Offerings
7.14.4 CSPC Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Cancer Targeted Small Molecule Therapy Major Product Offerings
7.16.4 Simcere Cancer Targeted Small Molecule Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
